Your privacy is very important to us. When you visit our website, please agree to the use of all cookies. For more information about personal data processing, please go to Privacy Policy.

d1banpc01.jpg d1banph01.jpg

pcicon015.svg phicon015.svg

  • Neurology
    • Therapeutic Area / Indication

      MECP2 Duplication Syndrome(MDS)

      Strategy

      RNA editing

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      Learn More

      d1icon02.svg
    • Therapeutic Area / Indication

      Huntington's Disease (HD)

      Strategy

      DNA editing

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      d1icon02.svg
    • Therapeutic Area / Indication

      Amyotrophic Lateral Sclerosis (ALS)

      Strategy

      DNA editing

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      d1icon02.svg
  • Ophthalmology
    • Therapeutic Area / Indication

      RPE65 Mutation-Associated Inherited Retinal Dystrophies (RPE65-IRDs)

      Strategy

      Gene Replacement

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      Learn More

      d1icon03.svg
    • Therapeutic Area / Indication

      Neovascular Age-related Macular Degeneration (nAMD)

      Strategy

      RNA editing

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      Learn More

      d1icon03.svg
    • Therapeutic Area / Indication

      RHO-Associated Retinitis Pigmentosa (RHO-adRP)

      Strategy

      DNA editing

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      Learn More

      d1icon03.svg
  • Neuromuscular
    • Therapeutic Area / Indication

      Duchenne Muscular Dystrophy (DMD)

      Strategy

      DNA editing

      Commercial Rights

      Global

      Discovery

      Optimization

      IND Enabling

      IIT / Phasel

      Phase Il / Ill

      Learn More

      d1icon05.svg